FDA.reportPublic FDA data

talazoparib 0.5 MG Oral Capsule [Talzenna]

RxCUI
2591512
RxNorm name
talazoparib 0.5 MG Oral Capsule [Talzenna]
Display name
talazoparib 0.5 MG Oral Capsule [Talzenna]
Full name
talazoparib 0.5 MG Oral Capsule [Talzenna]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TalzennaTALAZOPARIBU.S. Pharmaceuticals13839d4f-6acf-4ffb-a128-79df593192732026-06-01Warnings, Adverse reactionsExact identifier
rxcui: 2591512
TalzennaTALAZOPARIBPfizer Laboratories Div Pfizer Incc6fd147f-a77e-4a0b-9280-e82ecc41b4be2026-04-10Warnings, Adverse reactionsExact identifier
rxcui: 2591512
TalzennaTALAZOPARIBPfizer Laboratories Div Pfizer Incf2423edd-6d24-495c-aec1-c2f457f08d9a2025-12-18Warnings, Adverse reactionsExact identifier
rxcui: 2591512
TalzennaTALAZOPARIBU.S. Pharmaceuticalsb653221e-971f-4452-92d4-797924f1ff592024-07-09Warnings, Adverse reactionsExact identifier
rxcui: 2591512

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f2423edd-6d24-495c-aec1-c2f457f08d9aTalzenna 0.5 MG Oral CapsulePSN19These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820251218
f2423edd-6d24-495c-aec1-c2f457f08d9aTalzenna 0.5 MG Oral CapsuleSY19These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820251218
f2423edd-6d24-495c-aec1-c2f457f08d9atalazoparib 0.5 MG Oral Capsule [Talzenna]SBD19These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820251218
c6fd147f-a77e-4a0b-9280-e82ecc41b4beTalzenna 0.5 MG Oral CapsuleSY4These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820260410
c6fd147f-a77e-4a0b-9280-e82ecc41b4betalazoparib 0.5 MG Oral Capsule [Talzenna]SBD4These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820260410
c6fd147f-a77e-4a0b-9280-e82ecc41b4beTalzenna 0.5 MG Oral CapsulePSN4These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820260410
b653221e-971f-4452-92d4-797924f1ff59talazoparib 0.5 MG Oral Capsule [Talzenna]SBD1These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820240709
b653221e-971f-4452-92d4-797924f1ff59Talzenna 0.5 MG Oral CapsulePSN1These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820240709
b653221e-971f-4452-92d4-797924f1ff59Talzenna 0.5 MG Oral CapsuleSY1These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820240709